We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




AI-Based Algorithm Significantly Reduce Miss Rates for Pulmonary Embolism on CT Imaging

By HospiMedica International staff writers
Posted on 01 Aug 2024

Pulmonary Embolism (PE) ranks as the third most common acute cardiovascular syndrome globally with a prevalence of 20%. More...

Untreated, PE can have a mortality rate as high as 35%, but this can be reduced to between 2 and 15% with rapid and appropriate treatment. The primary diagnostic tool for PE is CT pulmonary angiography (CTPA), a non-invasive test that is both widely available and quick to perform, capable of detecting emboli with high sensitivity and specificity. However, diagnosing PE remains complex due to the presence of other conditions that can appear similar on scans, such as tumors, lymph nodes, artifacts, and lung nodules. Studies have indicated that delays or gaps in PE diagnosis are a leading cause of preventable deaths due to missed diagnoses. Now, a new study has shown that an artificial intelligence (AI)-based algorithm can substantially reduce the rates of missed PE diagnoses on CT scans.

For the study, researchers from University of California Irvine (Irvine, CA, USA) retrospectively collected 1204 CTPAs from 230 US cities, utilizing 57 different scanner models from six manufacturers. The gold standard, or ground truth, was established by consensus among three US board-certified expert radiologists. These cases were also assessed by an AI algorithm named CINA-PE, designed to detect and identify suspected PE locations. The algorithm’s effectiveness was measured both per case and per-finding.

Analysis included cases where PEs were present but not reported clinically, yet were identified by the AI. Of the 196 confirmed cases, 29 (15.6%) were initially unreported. The AI algorithm successfully identified 22 of these 29 cases, thus reducing the miss rate from 15.6% to 3.8% (7 missed out of 186 cases). These findings, published in the journal Clinical Imaging, suggest that AI integration into clinical settings can enhance the accuracy of PE diagnosis, leading to better patient outcomes through timely treatments. The implementation of such AI tools could significantly reduce the incidence of overlooked or delayed diagnoses, improving overall healthcare delivery and patient care.

Related Links:
University of California Irvine


Gold Member
12-Channel ECG
CM1200B
Hand-held Hemoglobin Analyzer
DiaSpect Tm
Gas Analyzer
GE SAM
Surgical Dressing
ALLEVYN Ag+ SURGICAL
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Illustration of the Hēlo Thrombectomy System device (Photo courtesty of Endovascular Engineering)

FDA-Cleared Thrombectomy System Removes Pulmonary Embolism Clots

Pulmonary embolism occurs when blood clots travel to the lungs and block blood flow, potentially requiring urgent endovascular intervention to prevent death. Catheter-based clot removal can be challenging,... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: Steris is expanding its healthcare consumables portfolio through an agreement to acquire Xodus Medical, a surgical products business focused on patient and operating room staff safety.

Steris to Expand Surgical Safety Portfolio With $2.1 Billion Xodus Medical Deal

Steris has signed a definitive agreement to acquire Xodus Medical, a specialty surgical products business based in Pennsylvania, for $2.1 billion at closing. The acquisition will expand Steris’s healthcare... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.